Ambroxol of / хл. таб. 0.03 No. 20

General characteristics. Structure:

Pharmacological properties:

Ambroxol – the mucolytic drug having sekretomotorny (expectorant) effect. Stimulates formation of surfactant, normalizes the changed bronchopulmonary secretion, improves phlegm indicators, reduces viscosity and adhesive properties, increases mukotsiliarny transport, facilitating removal of a phlegm from bronchial tubes.

Indications to use:

Acute and chronic bronchitis, pneumonia, bronchial asthma with difficulty of an otkhozhdeniye of a phlegm, a bronchoectatic disease.

Route of administration and doses:

The adult in the first 2 - 3 days appoint on 1 tablet 3 times a day, then on 1 tablet 2 times a day. To children aged from 6 up to 12 years usually appoint on 1 tablet 2-3 times a day. The pill Ambroksol-LH is taken inside after food, washing down with enough warm liquid. Duration of treatment is defined by the doctor individually.

Features of use:

In need of purpose of drug during feeding it is necessary to resolve by a breast an issue of the breastfeeding termination. There are no data on influence of drug on ability to manage transport.

Side effects:

At use of drug can arise: weakness, headache, gastralgias, nausea, vomiting, diarrhea, dieback.

Interaction with other medicines:

Simultaneous use of tablets of drug with the medicines having antibechic activity (for example, containing codeine), because of difficulty of removal of a phlegm from bronchial tubes against the background of suppression of a tussive reflex is not recommended. Drug increases efficiency of ampicillin and amoxicillin, increasing their concentration in a blood plasma. Therapeutic the drug combination with theophylline is reasonable, use with cardiac glycosides, diuretics and antibiotics is possible.

Contraindications:

Drug is contraindicated at a peptic ulcer of a stomach and a 12-perstny gut, the first trimester of pregnancy, hypersensitivity to Ambroxol or components of drug.

Overdose:

About overdose cases by drug it was not reported.

Storage conditions:

In the place protected from light at a temperature not over +25 °s.khranit in the place, unavailable to children.

Issue conditions:

Without recipe

Packaging:

On 10 tablets in a blister strip packaging, po1 or 2 blister strip packagings in a pack from a cardboard.